BD, ElArabi Pharma Group and AMECO are Dominating the Egypt Syringes, Auto Disable Syringe and IV Cannulas Market in 2020

Egypt Syringes, Auto Disable Syringe and IV Cannulas Market is expected to grow with the CAGR of 4.6% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @

Egypt syringes, auto disable syringe and IV cannulas market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in Egypt syringes, auto disable syringe and IV cannulas market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio.

BD is the dominating player in the market and the other players in the market are ElArabi Pharma Group, AMECO, Polymedicure, Intermedica, Denex International, Sterimed Group, ELDAWLIA, AdvaCare Pharma and Ultramedumic.

For instance,

  • In February 2021, Polymedicure's QIP committee approved allotment of 76,33,587 equity shares to eligible qualified institutional buyers at the issue price of Rs 524 per equity share, aggregating to Rs 400 crore. Polymedicure plans to use the net proceeds to support acceptable organic and inorganic development opportunities, continuing capital spending, other long-term and short-term provisions, prepayment and/or redemption of unpaid borrowings, general corporate intent or some other purpose as may be allowed under applicable legislation and approved by the Board of Director. This will help increase the net profit of the company.

Egypt Syringes, Auto Disable Syringe and IV Cannulas Market


BD has headquartered in New Jersey, U.S. was founded in 1897. The company is engaged in the development, manufacturing and sale of wide range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.           The company has presence in North America, South America, Europe, Asia-Pacific, Middle and Africa with its various subsidiaries such as Accuri Cytometers, Inc. (Delaware), Accuri Cytometers (Europe), Ltd. (U.K.), Atto Bioscience, Inc. (Delaware), B-D (U.K.) Ltd. (U.K.) among others.

For instance,

  • In January 2021, syringe manufacturer BD has negotiated with the U.S. government to supply 286 million syringes for use with COVID-19 vaccines including about 40 million low dead space syringes and is completely prepared to comply with this arrangement. This will boost the supply chain of the company.

ElArabi Pharma Group

ElArabi Pharma Group headquartered in Cairo, Egypt. The company provides a fully integrated service, which includes all the required resources and facilities for pharmaceutical factories to export their products. The company has wide presence across the world as Middle East and Africa.


AMECO has headquartered in Cairo, Egypt, was founded in 1984. The company focuses on manufacturing of single-use syringe and medical equipment including hypodermic needles, transfusion sets and disposable syringes. The company provides Syringes, IV Sets, Hypodermic Needles, Retrago. The company has presence in Egypt.